| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Mirabegron |
| Appearance | White Powder |
| CAS No. | 223673-61-8 |
| MF | C21h24n4o2s |
| MW | 396.51 |
Mirabillon is prone to interact with clinically relevant drugs such as cytochrome CYP2D6 substrates and CYP3A4 inhibitors. Research has shown that Mirabilon increases plasma exposure to demethylamine (drugs with CYP2D6 substrates), reversibly prolonging drug half-life. Other studies have shown that different doses of ketoconazole (a strong CYP3A4 inhibitor) can inhibit the clearance rate of Mirabillon in healthy adults, while repeated doses of rifampicin (inducing CYP3A4 metabolism) can lead to moderate reductions in Mirabillon plasma concentrations.
){kind=link}